title: Analysis of gene expression identifies candidate markers and pathways in pre-eclampsia.
abstract: Pre-eclampsia is a serious multisystem disorder and causes significant increase in both maternal and foetal morbidity and perinatal mortality globally. Due to the limited understanding of the molecular mechanism of pre-eclampsia, the current study conducted bioinformatic analyses to screen key regulators involved in pre-eclampsia. The gene expression profiling dataset GSE44711 containing 8 early-onset pre-eclampsia placentas and 8 gestational-age-matched control placentas was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened by limma software package, which were then subjected to Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis on the Database for Annotation, Visualization, and Integrated Discovery website. Finally, protein-protein interaction network was constructed using the Search Tool for the Retrieval of Interacting Genes database. In total, 192 DEGs including 106 upregulated and 86 downregulated genes were obtained. Proteoglycan 2 and podoplanin were the most significantly up- and downregulated genes, respectively. In addition, three potential pathways and their related DEGs: spermidine/spermine N1-acetyltransferase 1, amiloride-binding protein 1 and adenosylmethionine decarboxylase 1 were associated with arginine and proline metabolism. Vascular endothelial growth factor C; phosphatidylinositol-4, 5-bisphosphate 3-kinase, catalytic subunit beta; collagen, type I, alpha 1 (COL1A1); and fibronectin 1 (FN1) were associated with focal adhesion. COL6A1 as well as COL1A1 and FN1 were involved in extra-cellular matrix-receptor interaction. The current study identified several potential genes and three pathways which may be considered as candidate targets for diagnosis and therapy of pre-eclampsia.
authors.affiliation: a Department of Physiological Obstetric , Guangzhou Women and Children's Medical Centre, Guangzhou Medical University , Guangzhou , P. R. China.
authors.forename: P
authors.initials: P
authors.lastname: He
authors.affiliation: b Guangzhou Medical Research and Development Centre of BGI , Guangzhou , P. R. China.
authors.forename: D
authors.initials: D
authors.lastname: Shao
authors.affiliation: b Guangzhou Medical Research and Development Centre of BGI , Guangzhou , P. R. China.
authors.forename: M
authors.initials: M
authors.lastname: Ye
authors.affiliation: a Department of Physiological Obstetric , Guangzhou Women and Children's Medical Centre, Guangzhou Medical University , Guangzhou , P. R. China.
authors.forename: G
authors.initials: G
authors.lastname: Zhang
mesh_terms: D015536:Down-Regulation; D047093:Eosinophil Major Basic Protein / Q000235:genetics; D005260:Female; D005865:Gestational Age; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics; D010920:Placenta / Q000378:metabolism; D011225:Pre-Eclampsia / Q000235:genetics*; D011247:Pregnancy; D011509:Proteoglycans / Q000235:genetics; D059467:Transcriptome; D015854:Up-Regulation; D000098853:Podoplanin
chemical_list: D047093:Eosinophil Major Basic Protein; D008562:Membrane Glycoproteins; D011509:Proteoglycans; C117468:PDPN protein, human; D000098853:Podoplanin; C074129:PRG2 protein, human
keywords: Cell adhesion; differentially expressed genes; nitric oxide; pathway; pre-eclampsia